DE69905376T2 - Enanthioauswählende synthese - Google Patents

Enanthioauswählende synthese

Info

Publication number
DE69905376T2
DE69905376T2 DE69905376T DE69905376T DE69905376T2 DE 69905376 T2 DE69905376 T2 DE 69905376T2 DE 69905376 T DE69905376 T DE 69905376T DE 69905376 T DE69905376 T DE 69905376T DE 69905376 T2 DE69905376 T2 DE 69905376T2
Authority
DE
Germany
Prior art keywords
formula
compound
produce
temperature
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69905376T
Other languages
German (de)
English (en)
Other versions
DE69905376D1 (de
Inventor
W. Draper
V. Iyer
Yuelie Lu
Eugene J. Vater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DE69905376D1 publication Critical patent/DE69905376D1/de
Application granted granted Critical
Publication of DE69905376T2 publication Critical patent/DE69905376T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE69905376T 1998-08-14 1999-08-12 Enanthioauswählende synthese Expired - Lifetime DE69905376T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13421698A 1998-08-14 1998-08-14
PCT/US1999/016711 WO2000009493A1 (en) 1998-08-14 1999-08-12 Enantioselective synthesis

Publications (2)

Publication Number Publication Date
DE69905376D1 DE69905376D1 (de) 2003-03-20
DE69905376T2 true DE69905376T2 (de) 2003-10-09

Family

ID=22462296

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69905376T Expired - Lifetime DE69905376T2 (de) 1998-08-14 1999-08-12 Enanthioauswählende synthese

Country Status (10)

Country Link
EP (1) EP1104414B1 (enExample)
JP (2) JP3684332B2 (enExample)
CN (1) CN1146554C (enExample)
AT (1) ATE232525T1 (enExample)
AU (1) AU5459399A (enExample)
CA (1) CA2340343C (enExample)
DE (1) DE69905376T2 (enExample)
ES (1) ES2188222T3 (enExample)
WO (1) WO2000009493A1 (enExample)
ZA (1) ZA200100875B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3205648A1 (en) 2010-06-10 2017-08-16 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
EP2791132A4 (en) 2011-12-14 2015-08-05 Seragon Pharmaceuticals Inc ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
BR112014014767A2 (pt) 2011-12-16 2017-06-13 Olema Pharmaceuticals Inc novos compostos de benzopirano, composições e usos dos mesmos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5254568A (en) * 1990-08-09 1993-10-19 Council Of Scientific & Industrial Research Benzopyrans as antiestrogenic agents
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
US5407947A (en) * 1993-11-05 1995-04-18 Eli Lilly And Company Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans
AU8102398A (en) * 1997-07-09 1999-02-08 Central Drug Research Institute (dl)-2,3-diaryl-2h-1-benzopyrans
AU8102498A (en) * 1997-07-09 1999-02-08 Central Drug Research Institute Preparation of diaryl-benzopyrans
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Also Published As

Publication number Publication date
ES2188222T3 (es) 2003-06-16
WO2000009493A1 (en) 2000-02-24
JP2002522533A (ja) 2002-07-23
CN1322200A (zh) 2001-11-14
CN1146554C (zh) 2004-04-21
CA2340343C (en) 2007-04-24
AU5459399A (en) 2000-03-06
JP3684332B2 (ja) 2005-08-17
ATE232525T1 (de) 2003-02-15
JP4461048B2 (ja) 2010-05-12
ZA200100875B (en) 2002-06-26
CA2340343A1 (en) 2000-02-24
DE69905376D1 (de) 2003-03-20
HK1036978A1 (en) 2002-01-25
JP2005206610A (ja) 2005-08-04
EP1104414A1 (en) 2001-06-06
EP1104414B1 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
DE69709938T2 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
DE69018215T2 (de) Verfahren zur Produktion von optisch aktivem Atenolol und Zwischenprodukt davon.
US6262270B1 (en) Enantioselective synthesis
EP3271337B1 (de) Verfahren zur herstellung von (4s)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluormethyl)phenyl]-1,2,3,4-tetrahydro pyrimidin-5-carbonitril
DE3887212T2 (de) Verfahren zur Herstellung von Derivaten von 6,7-Diazyl-7-desacetylforskolin.
DE69913955T2 (de) Ein verbessertes synthese- und reinigungsverfahren für (r*,r*)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl) cyclohexanol hydrochlorid
DE69900892T2 (de) Verfahren zur Herstellung von Racemisch Sertralin
CN114315609B (zh) 一种制备顺式2-氨基环己醇的工艺方法
DE69409001T2 (de) Chirale nitrile, ihre herstellung und ihre verwendung in der herstellung von verapamil und dessen analogen
CN109988083B (zh) 高光学纯度草酸艾司西酞普兰中间体s构型二醇的制备方法
EP4279487B1 (en) Purification method for citalopram or s-citalopram
DE60010090T2 (de) Verfahren zur cis-selektiven katalytischen hydrierung von cyclohexylidenaminen
DE69623117T2 (de) Verfahren zur herstellung von 4-hydroxy-2-pyrrolidon
DE69708136T2 (de) Selektive alkylierung einer durch einen alkohol substituierten phenolverbindung
EP1104414B1 (en) Enantioselective synthesis
CN117142999A (zh) 一种药物中间体的消旋化方法
HU194857B (en) Process for production of 4-amin-6-fluor-cromane-4-carbonic acid and its 2/r/ methilesther
EP1968960B1 (de) Racematspaltung von 2,6-trans-dimethylmorpholin
JPH0256354B2 (enExample)
US4997984A (en) Process for preparation of N-(α-alkoxyethyl)-carboxylic acid amide
JP2002371060A (ja) 光学活性アミノピペリジン誘導体の製造方法
DE60103530T2 (de) Verfahren zur Herstellung von 5-Formylphthalide
US4254279A (en) Ester resolution process
DE69301324T2 (de) Verfahren zur Herstellung optisch aktivem 4-Hydroxy-2-Cyclopentenon
DE2658064C2 (enExample)